Applied Genetic Technologies reported $-13583000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Alimera Sciences ALIM:US $ -2.75M 0.73M
Applied Genetic Technologies AGTC:US $ -13.58M 4.86M
Avrobio Inc AVRO:US -29418000 1.46M
Bluebird Bio BLUE:US $ -135.67M 81.29M
Celldex Therapeutics CLDX:US $ -23.26M 2.92M
Ophthotech OPHT:US $ -34.67M 1.57M